T2 Mapping Cardiovascular Magnetic Resonance Is an Independent Predictor of Adverse Outcome in Hypertrophic Cardiomyopathy
Cardiology · 2025
DOI: 10.1159/000547262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, 2025. Verfasst von Yafim Brodov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diagnostic Imaging, Sheba Medical Center, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel, yafim.brodov@gmail.com. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Tachycardia, Ventricular, Magnetic Resonance Imaging, Magnetic Resonance Imaging, Cine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Introduction
The outcome of patients with hypertrophic cardiomyopathy (HCM) largely depends on the presence of ventricular arrhythmias. T2 mapping is a well-documented cardiovascular magnetic resonance (CMR) sequence for edema evaluation and quantification. Our aim was to evaluate whether T2 mapping values might predict ventricular arrythmias and clinical outcome in patients with HCM.
Methods
Consecutive patients (n = 48, mean age 50 ± 18 years) with HCM and healthy volunteers (n = 21, mean age 44 ± 5 years) underwent a CMR scan (3 Tesla scanner). T2 mapping values were presented using a 16-segment AHA model and divided into 3 tertiles. Late gadolinium enhancement (LGE) was calculated as percentage of left ventricular mass. Ventricular tachycardia (VT) was recorded by 24-h Holter monitoring or during exercise stress test. The clinical endpoint was defined as the presence of VT, admission due to arrhythmias, and implantable cardioverter defibrillator insertion.
Results
The clinical endpoint was documented in 69%, 62%, and 50% of the third, second, and first T2 mapping tertiles, respectively (p for trend = 0.03). A multivariate analysis including age, gender, LGE, and T2 mapping demonstrated that T2 mapping was an independent predictor of the clinical endpoint as a continuous variable (OR 1.56; 1.03–2.38, p = 0.04) and the third T2 tertile (OR 22.80; 1.40–361.60, p = 0.03), respectively.
Conclusion
Elevated T2 mapping values were found to be an independent predictor of the clinical endpoint in HCM patients. These results highlight the potential role of edema in HCM arrhythmias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Diagnostic Imaging, Sheba Medical Center, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel, yafim.brodov@gmail.com.
- Heart Institute, Sheba Medical Center, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel, yafim.brodov@gmail.com.
- Division of Diagnostic Imaging, Sheba Medical Center, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
- Heart Institute, Sheba Medical Center, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Zitieren
APA
Brodov, Y., Kirshenboim, Z., Fardman, A., Shagraui, R., Sabbag, A., Konen, E., Beytelman, A., Arad, M., Wassershtrum, Y., & Goitein, O. (2025). T2 Mapping Cardiovascular Magnetic Resonance Is an Independent Predictor of Adverse Outcome in Hypertrophic Cardiomyopathy. Cardiology. https://doi.org/10.1159/000547262
Vancouver
Brodov Y, Kirshenboim Z, Fardman A, Shagraui R, Sabbag A, Konen E, et al. T2 Mapping Cardiovascular Magnetic Resonance Is an Independent Predictor of Adverse Outcome in Hypertrophic Cardiomyopathy. Cardiology. 2025. doi:10.1159/000547262
BibTeX
@article{Brodov2025,
author = {Brodov, Yafim and Kirshenboim, Zehavit and Fardman, Alexander and Shagraui, Rayiq and Sabbag, Avi and Konen, Eli and Beytelman, Arkadi and Arad, Michael and Wassershtrum, Yishay and Goitein, Orly},
title = {T2 Mapping Cardiovascular Magnetic Resonance Is an Independent Predictor of Adverse Outcome in Hypertrophic Cardiomyopathy},
journal = {Cardiology},
year = {2025},
doi = {10.1159/000547262}
}
EUVIMED